Literature DB >> 26971958

Osteogenesis in calcified aortic valve disease: From histopathological observation towards molecular understanding.

Xiaohong Liu1, Zhiyun Xu2.   

Abstract

Calcified aortic valve disease (CAVD) is the most common heart valve disease in aged patients, with a disease continuum that ranges from mild valve thickening to severe calcification. In the past, calcification in CAVD was considered degenerative because of the time-dependent wear-and-tear of the leaflets with passive calcium deposition. Now, insights into the histopathological features, clinical data, and molecular mechanisms of CAVD have been greatly highlighted by findings that valvular calcification is a tightly regulated process resembling the osteogenic process. In this review, we focus on osteogenesis (bone formation) during the progression of CAVD and highlight the recent advances in understanding the cellular and molecular mechanisms of osteogenesis in valvular calcification.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Calcification; Calcified aortic valve disease; Osteogenesis

Mesh:

Year:  2016        PMID: 26971958     DOI: 10.1016/j.pbiomolbio.2016.02.002

Source DB:  PubMed          Journal:  Prog Biophys Mol Biol        ISSN: 0079-6107            Impact factor:   3.667


  10 in total

Review 1.  WNT Signaling in Cardiac and Vascular Disease.

Authors:  Sébastien Foulquier; Evangelos P Daskalopoulos; Gentian Lluri; Kevin C M Hermans; Arjun Deb; W Matthijs Blankesteijn
Journal:  Pharmacol Rev       Date:  2018-01       Impact factor: 25.468

Review 2.  Cell Sources for Tissue Engineering Strategies to Treat Calcific Valve Disease.

Authors:  Eva Jover; Marco Fagnano; Gianni Angelini; Paolo Madeddu
Journal:  Front Cardiovasc Med       Date:  2018-11-06

3.  Treatment with XAV-939 prevents in vitro calcification of human valvular interstitial cells.

Authors:  Claudia Dittfeld; Gabriel Reimann; Alice Mieting; Petra Büttner; Anett Jannasch; Katrin Plötze; Gerald Steiner; Sems Malte Tugtekin; Klaus Matschke
Journal:  PLoS One       Date:  2018-12-07       Impact factor: 3.240

Review 4.  Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities.

Authors:  Jiaqi Liu; Qing Xiao; Jiani Xiao; Chenxi Niu; Yuanyuan Li; Xiaojun Zhang; Zhengwei Zhou; Guang Shu; Gang Yin
Journal:  Signal Transduct Target Ther       Date:  2022-01-03

5.  Calcium-Dependent Cytosolic Phospholipase A2α as Key Factor in Calcification of Subdermally Implanted Aortic Valve Leaflets.

Authors:  Antonella Bonetti; Magali Contin; Federica Tonon; Maurizio Marchini; Fulvia Ortolani
Journal:  Int J Mol Sci       Date:  2022-02-11       Impact factor: 5.923

6.  Adropin Inhibits Vascular Smooth Muscle Cell Osteogenic Differentiation to Alleviate Vascular Calcification via the JAK2/STAT3 Signaling Pathway.

Authors:  Li Wang; Fulu Jin; Peiyu Wang; Shiqiang Hou; Tao Jin; Xiansong Chang; Liangping Zhao
Journal:  Biomed Res Int       Date:  2022-07-27       Impact factor: 3.246

7.  Integrated identification of key immune related genes and patterns of immune infiltration in calcified aortic valvular disease: A network based meta-analysis.

Authors:  Li-Da Wu; Feng Xiao; Jin-Yu Sun; Feng Li; Yu-Jia Chen; Jia-Yi Chen; Jie Zhang; Ling-Ling Qian; Ru-Xing Wang
Journal:  Front Genet       Date:  2022-09-21       Impact factor: 4.772

8.  Ginkgo Biloba Extract EGB761 Alleviates Warfarin-induced Aortic Valve Calcification Through the BMP2/Smad1/5/Runx2 Signaling Pathway.

Authors:  Jing Liu; Cuiying Liu; Chunqi Qian; George Abela; Wei Sun; Xiangqing Kong
Journal:  J Cardiovasc Pharmacol       Date:  2021-09-01       Impact factor: 3.271

9.  Abundant dystrophic calcifications mimicking aortic valve abscess in a patient undergoing elective aortic valve replacement.

Authors:  Adam L Booth; Christine Q Li; Ghannam Ayed Al-Dossari; Heather L Stevenson
Journal:  BMJ Case Rep       Date:  2017-07-19

10.  Pro-inflammatory mediators released by activated monocytes promote aortic valve fibrocalcific activity.

Authors:  Peijian Zhang; Erlinda The; Zichao Luo; Yufeng Zhai; Qingzhou Yao; Lihua Ao; David A Fullerton; Dingli Xu; Xianzhong Meng
Journal:  Mol Med       Date:  2022-01-21       Impact factor: 6.354

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.